Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Trudgett

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Parasitology|March 9, 2004
The occurrence and significance of triploidy in the liver fluke, Fasciola hepaticaH L Fletcher, E M Hoey, N Orr, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 13, 2010
Genetic diversity of liver flukes (Fasciola hepatica) from Eastern EuropeD Teofanova, V Kantzoura, S Walker, et al.
Archives of Virology|January 1, 1992
Characteristics of a cetacean morbillivirus isolated from a porpoise (Phocoena phocoena)M J Welsh, C Lyons, A Trudgett, et al.
Parasitology Research|March 29, 2011
Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Parasitology|October 16, 2010
Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Parasitology Research|August 23, 2011
Erratum to: inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Parasitology|December 23, 2009
Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazoleC Devine, G P Brennan, C E Lanusse, et al.
Parasitology|December 17, 2008
Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Microtubules as antiparasitic drug targetsBj Fennell, Ja Naughton, J Barlow, et al.
Veterinary Parasitology|January 7, 2011
Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazoleC Devine, G P Brennan, C E Lanusse, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Parasitology|March 9, 2004
The occurrence and significance of triploidy in the liver fluke, Fasciola hepaticaH L Fletcher, E M Hoey, N Orr, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 13, 2010
Genetic diversity of liver flukes (Fasciola hepatica) from Eastern EuropeD Teofanova, V Kantzoura, S Walker, et al.
Archives of Virology|January 1, 1992
Characteristics of a cetacean morbillivirus isolated from a porpoise (Phocoena phocoena)M J Welsh, C Lyons, A Trudgett, et al.
Parasitology Research|March 29, 2011
Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Parasitology|October 16, 2010
Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Parasitology Research|August 23, 2011
Erratum to: inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Parasitology|December 23, 2009
Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazoleC Devine, G P Brennan, C E Lanusse, et al.
Parasitology|December 17, 2008
Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepaticaC Devine, G P Brennan, C E Lanusse, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Microtubules as antiparasitic drug targetsBj Fennell, Ja Naughton, J Barlow, et al.
Veterinary Parasitology|January 7, 2011
Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazoleC Devine, G P Brennan, C E Lanusse, et al.
Pageof 6